[ad_1]
Reports of side effects from a vaccine that so far appeared to pose no health risks came just days after pharmaceutical giant Pfizer and its German partner BioNTech announced about 90 percent. Vaccine efficacy in protecting against coronavirus infection. Pharmaceutical companies are already hopeful that the US will be allowed to use the vaccine in November.
At the time of the trial, 46,500 volunteers from six states were not informed whether they had received a real vaccine or a placebo.
Some volunteers said they thought they had been vaccinated with a real vaccine because they felt various side effects: headaches, muscle aches, etc.
Glenn Deshields, 44, of Austin, Texas, told the Press Association that he felt a side effect that reminded him of a severe hangover, although the unpleasant sensations quickly disappeared. The man was subsequently tested for antibodies, which showed that he had already developed antibodies to the virus in his body, confirming the speculation that he had been given real vaccines.
Volunteer Carrie, a 45 year old Missouri woman said she had a fever, headache and whole body after the first injection. According to the woman, she felt similar after the flu shot, and after the second shot of the vaccine, the flu-like symptoms got worse.
A report on the efficacy of the vaccine by Dr. Albert Bourl, CEO of Pfizer, published last Monday, said: “Today is a happy day for science and humanity. Preliminary results of studies with the phase 3 vaccine against Covid-19 show that our vaccine is capable of protecting against Covid-19. We have reached this significant stage in the vaccine development program at a time when the world needs it most, when infection rates are breaking new records, hospitals are becoming overcrowded as recovery efforts unfold. [šalių] economy. With today’s news, we are one step closer to the breakthrough we must achieve <...>to stop this global health crisis. We look forward to announcing even more efficiency and safety data collected from thousands of participants in the coming weeks. “
According to Reuters, questions remain about the vaccine’s effectiveness for people of all ages and ethnic groups, as well as whether long-term immunity is acquired.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source .
[ad_2]
